From: Amphiregulin as a novel diagnostic and prognostic biomarker of hepatocellular carcinoma before and after locoregional treatment
Marker
AUC
Sensitivity (%)
Specificity (%)
SE
P
95% CI
Cutoff
Follow-up AFP
0.784
60
92
0.100
0.048*
0.588–0.980
≥ 1993.0
Follow-up amphiregulin
0.800
96
0.120
0.037*
0.464–1.000
≥ 29.7